These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17213405)

  • 1. Does clopidogrel each day keep stent thrombosis away?
    Kereiakes DJ
    JAMA; 2007 Jan; 297(2):209-11. PubMed ID: 17213405
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
    Eisenstein EL; Anstrom KJ; Kong DF; Shaw LK; Tuttle RH; Mark DB; Kramer JM; Harrington RA; Matchar DB; Kandzari DE; Peterson ED; Schulman KA; Califf RM
    JAMA; 2007 Jan; 297(2):159-68. PubMed ID: 17148711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent.
    Spinler SA; Wilensky RL
    Am J Health Syst Pharm; 2007 Jul; 64(13):1432-4. PubMed ID: 17592011
    [No Abstract]   [Full Text] [Related]  

  • 4. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Alfonso F
    JAMA; 2007 Apr; 297(16):1769; author reply 1770-1. PubMed ID: 17456814
    [No Abstract]   [Full Text] [Related]  

  • 5. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Falcone EL; Tangri N
    JAMA; 2007 Apr; 297(16):1770; author reply 1770-1. PubMed ID: 17456815
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Khurana A; Vinayek N
    JAMA; 2007 Apr; 297(16):1769; author reply 1770-1. PubMed ID: 17456813
    [No Abstract]   [Full Text] [Related]  

  • 7. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Matteau A; LeLorier J
    JAMA; 2007 Apr; 297(16):1770; author reply 1770-1. PubMed ID: 17456816
    [No Abstract]   [Full Text] [Related]  

  • 8. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation.
    Joyal D; Rudski L
    J Invasive Cardiol; 2007 Sep; 19(9):E265-7. PubMed ID: 17827517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].
    Baralis G; Steffenino G; Dellavalle A; La Scala E; Uslenghi E
    Ital Heart J Suppl; 2003 Sep; 4(9):766-70. PubMed ID: 14635395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease: Platelet activity: an obstacle for successful PCI.
    Gawaz M; Geisler T
    Nat Rev Cardiol; 2009 Jun; 6(6):391-2. PubMed ID: 19471282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The excel stent: a good DES, but can we really stop clopidogrel after 6 months?
    Margolis JR
    JACC Cardiovasc Interv; 2009 Apr; 2(4):310-1. PubMed ID: 19463442
    [No Abstract]   [Full Text] [Related]  

  • 12. Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
    Sardella G; Bucciarelli-Ducci C; Mancone M; Colantonio R; Sangiorgi GM; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):625-8. PubMed ID: 17667035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel and coronary stents: risks and benefits.
    Mood GR; Bavry AA; Bhatt DL
    Curr Atheroscler Rep; 2008 Aug; 10(4):303-8. PubMed ID: 18606101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.
    Caixeta A; Lansky AJ; Serruys PW; Hermiller JB; Ruygrok P; Onuma Y; Gordon P; Yaqub M; Miquel-Hebert K; Veldhof S; Sood P; Su X; Jonnavithula L; Sudhir K; Stone GW;
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1220-8. PubMed ID: 21232715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants.
    Zavalloni D; Belli G; Rossi M; Presbitero P
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):544-6. PubMed ID: 17568291
    [No Abstract]   [Full Text] [Related]  

  • 16. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent.
    Shammas NW; Dippel EJ; Avila A; Gehbauer L; Farland L; Brosius S; Jerin M; Winter M; Stoakes P; Byrd J; Majetic L; Shammas G; Sharis P; Robken J
    J Invasive Cardiol; 2007 Feb; 19(2):77-82. PubMed ID: 17268042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.